← All organizations

TiGenix

For profit

Also known as: TiGenix n.v. | TiGenix S.A.U.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 15, 2017

Acquired by Takeda on Jan 5, 2018

Timeline

2000s

Jun 1, 2000
TiGenix— Founded

2010s

Feb 25, 2011
Cellerix— Acquired
Nov 30, 2011
Orthomimetics— Acquired
Jan 5, 2018
Takeda— Acquired By

Drugs by trial phase (6 distinct, 10 trials)

Phase 3 (2 own, 2 via acquisition)

Phase 2 (1 own, 1 via acquisition)

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (6)

NCT03279081Lead sponsorPhase 3Sep 15, 2017
NCT03158727Lead sponsorPhase 1/Phase 2Jan 30, 2017
NCT01541579Lead sponsorPhase 3Jul 31, 2012
NCT01743222Lead sponsorPhase 1Jan 1, 2012
NCT01663116Lead sponsorPhase 1/Phase 2Mar 1, 2011
NCT00414700Lead sponsorPhase 3Feb 1, 2002

Details

Founded: Leuven, BE Jun 1, 2000
Last known activity: Sep 15, 2017